Cyclosporin A preserves mitochondrial function after traumatic brain injury in the immature rat and piglet.
Cyclosporin A (CsA) has been shown to be neuroprotective in mature animal models of traumatic brain injury (TBI), but its effects on immature animal models of TBI are unknown. In mature animal models, CsA inhibits the opening of the mitochondrial permeability transition pore (MPTP), thereby maintaining mitochondrial homeostasis following injury by inhibiting calcium influx and preserving mitochondrial membrane potential. The aim of the present study was to evaluate CsA's ability to preserve mitochondrial bioenergetic function following TBI (as measured by mitochondrial respiration and cerebral microdialysis), in two immature models (focal and diffuse), and in two different species (rat and piglet). Three groups were studied: injured+CsA, injured+saline vehicle, and uninjured shams. In addition, we evaluated CsA's effects on cerebral hemodynamics as measured by a novel thermal diffusion probe. The results demonstrate that post-injury administration of CsA ameliorates mitochondrial dysfunction, preserves cerebral blood flow (CBF), and limits neuropathology in immature animals 24 h post-TBI. Mitochondria were isolated 24 h after controlled cortical impact (CCI) in rats and rapid non-impact rotational injury (RNR) in piglets, and CsA ameliorated cerebral bioenergetic crisis with preservation of the respiratory control ratio (RCR) to sham levels. Results were more dramatic in RNR piglets than in CCI rats. In piglets, CsA also preserved lactate pyruvate ratios (LPR), as measured by cerebral microdialysis and CBF at sham levels 24 h after injury, in contrast to the significant alterations seen in injured piglets compared to shams (p<0.01). The administration of CsA to piglets following RNR promoted a 42% decrease in injured brain volume (p<0.01). We conclude that CsA exhibits significant neuroprotective activity in immature models of focal and diffuse TBI, and has exciting translational potential as a therapeutic agent for neuroprotection in children.
University of Pennsylvania School of Medicine, Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Todd J
TJ
Kilbaugh
Sunita
S
Bhandare
David H
DH
Lorom
Manda
M
Saraswati
Courtney L
CL
Robertson
Susan S
SS
Margulies
D000818:Animals; D001930:Brain Injuries / Q000188:drug therapy* / Q000473:pathology; D019069:Cell Respiration / Q000187:drug effects; D002560:Cerebrovascular Circulation / Q000187:drug effects; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D017551:Microdialysis; D008928:Mitochondria / Q000187:drug effects*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013552:Swine
D007166:Immunosuppressive Agents; D018696:Neuroprotective Agents; D016572:Cyclosporine
J Neurotrauma. 2009 Dec;26(12):2195-206
19621985
Dev Neurosci. 2006;28(4-5):420-31
16943665
Acta Neurochir Suppl. 2005;95:441-5
16463898
J Neurotrauma. 2009 Aug;26(8):1271-80
19637966
J Neurosurg. 2000 Aug;93(2):265-74
10930012
Cell Calcium. 2004 Sep-Oct;36(3-4):257-64
15261481
Natl Vital Stat Rep. 2006 Apr 19;54(13):1-120
16689256
Curr Pharm Des. 2006;12(13):1645-80
16729876
Brain Res. 1999 Aug 28;839(2):283-91
10519051
Exp Neurol. 2011 Jul;230(1):58-66
20599982
J Neurotrauma. 1997 Jan;14(1):23-34
9048308
J Neurotrauma. 2008 Jun;25(6):603-14
18454682
Stroke. 2009 Jun;40(6):2244-50
19246690
Intensive Care Med. 2004 Dec;30(12):2166-9
15549254
J Neurotrauma. 2002 May;19(5):503-57
12042091
Epilepsy Behav. 2005 Dec;7 Suppl 3:S12-7
16239125
Physiol Rev. 2000 Jan;80(1):315-60
10617771
J Neurochem. 2003 Jun;85(6):1431-42
12787063
Brain Res. 2010 Nov 4;1359:208-15
20735992
J Neurotrauma. 2010 Jun;27(6):1021-35
20560753
Brain Res. 1992 Nov 6;595(1):145-8
1467951
J Neurotrauma. 2003 Apr;20(4):381-90
12866817
Epilepsy Res. 2004 Sep-Oct;61(1-3):63-72
15451009
Acta Neuropathol. 1995;89(6):537-43
7676809
Brain Res Mol Brain Res. 2004 Feb 5;121(1-2):50-9
14969736
J Neurotrauma. 1994 Oct;11(5):487-97
7861442
Clin Pharmacokinet. 2002;41(2):115-35
11888332
Mol Neurobiol. 2005;31(1-3):105-16
15953815
Hypertension. 2003 Oct;42(4):754-60
12874088
J Neurotrauma. 2004 Mar;21(3):307-16
15115605
Brain Res. 1998 Nov 23;812(1-2):216-26
9813336
Curr Opin Crit Care. 2009 Apr;15(2):110-7
19578321
Pediatr Neurol. 2004 Apr;30(4):247-53
15087102
Acta Anaesthesiol Scand. 2010 Aug;54(7):804-13
20455870
Dev Neurosci. 1994;16(5-6):321-7
7768212
J Neurochem. 2002 Oct;83(1):220-8
12358746
Acta Neurochir Suppl. 2003;87:81-3
14518529
Brain Res. 2003 Jan 17;960(1-2):99-111
12505662
Dev Neurosci. 2006;28(4-5):432-46
16943666
J Neurotrauma. 2009 Jul;26(7):1111-21
19275468
Acta Neurochir Suppl. 2003;86:301-3
14753457
Exp Neurol. 2009 Aug;218(2):371-80
19427308
J Cereb Blood Flow Metab. 2005 Jun;25(6):763-74
15716852
J Head Trauma Rehabil. 2003 Jul-Aug;18(4):307-16
16222127
Neurobiol Dis. 2002 Aug;10(3):219-33
12270685
FASEB J. 2008 Mar;22(3):659-61
17942826
J Child Neurol. 2006 Oct;21(10):879-85
17005105
Br J Anaesth. 2007 Jul;99(1):18-31
17545555
J Neurotrauma. 2004 Sep;21(9):1154-67
15453986
Crit Care Clin. 2003 Jul;19(3):529-49
12848319
Exp Neurol. 2000 Feb;161(2):631-7
10686082
Neuroscience. 2000;101(2):289-95
11074152
J Cereb Blood Flow Metab. 2009 Jan;29(1):87-97
18714331
Acta Neuropathol. 2001 Dec;102(6):581-90
11761718
Neurochem Int. 2006 Apr;48(5):394-403
16473439
Nature. 2006 Oct 19;443(7113):787-95
17051205
Ann Neurol. 1982 Dec;12(6):557-63
7159059
Pediatr Crit Care Med. 2003 Jul;4(3 Suppl):S2-4
12847337
N Engl J Med. 2008 Jun 5;358(23):2447-56
18525042
J Cereb Blood Flow Metab. 1999 Apr;19(4):443-51
10197514
J Neurotrauma. 1999 Sep;16(9):783-92
10521138
J Neuropathol Exp Neurol. 2000 Aug;59(8):641-51
10952055
Acta Anaesthesiol Scand. 2001 Sep;45(8):977-85
11576049
J Neurochem. 2007 Jun;101(5):1248-57
17403141
Crit Care Med. 1999 Sep;27(9):1965-73
10507626
Childs Nerv Syst. 2006 Oct;22(10):1268-74
16496158
Curr Opin Crit Care. 2006 Apr;12(2):112-8
16543785
J Neurotrauma. 2009 Jun;26(6):925-39
19331514
Mech Ageing Dev. 1987 Nov;41(1-2):29-38
3431167
J Head Trauma Rehabil. 2005 Jan-Feb;20(1):76-94
15668572
J Neurosurg. 2004 May;100(5 Suppl Pediatrics):454-9
15287454
Exp Neurol. 1999 Nov;160(1):226-34
10630207
J Neurotrauma. 2008 Jul;25(7):719-38
18627252
J Neurotrauma. 2002 Jul;19(7):843-53
12184854
J Neurotrauma. 2000 Oct;17(10):843-55
11063052
J Neurosurg. 2000 Sep;93(3):455-62
10969944
J Neurochem. 2002 Feb;80(3):531-8
11905998
Neuroreport. 1999 Feb 5;10(2):353-8
10203334
J Neurotrauma. 2005 Jan;22(1):42-75
15665602
Curr Opin Crit Care. 2007 Apr;13(2):134-42
17327733
Br J Anaesth. 2007 Jul;99(1):4-9
17573392
Neurobiol Aging. 2007 Oct;28(10):1532-42
16876914
Acta Neurochir Suppl (Wien). 1983;32:15-30
6581702
J Cereb Blood Flow Metab. 2006 Nov;26(11):1407-18
16538231
Acta Neurochir (Wien). 2008 Oct;150(10):1019-31; discussion 1031
18781275
Biochim Biophys Acta. 1992 Apr 7;1134(3):223-32
1558846
J Neurotrauma. 2007 Jan;24(1):5-14
17263666
J Neurotrauma. 2007;24 Suppl 1:S1-106
17511534
Exp Brain Res. 1997 Mar;114(1):44-50
9125450
J Neurotrauma. 2002 Jul;19(7):829-41
12184853
Exp Neurol. 2000 Sep;165(1):153-63
10964494
J Neurochem. 2003 Sep;86(5):1101-7
12911618
Cell Death Differ. 2003 Mar;10(3):365-70
12700636
Transplant Proc. 2007 May;39(4):1219-22
17524937